Dengue is an infectious disease caused by dengue virus (DENV). In general, dengue is a
self‐limiting acute febrile illness followed by a phase of critical defervescence, in which …

Dengue virus belongs to family Flaviviridae, having four serotypes that spread by the bite of
infected Aedes mosquitoes. It causes a wide spectrum of illness from mild asymptomatic …

Background Dengue is the commonest vector-borne infection worldwide. It is often
associated with thrombocytopenia, and prophylactic platelet transfusion is widely used …

summary Dengue is the most common arthropod‐borne infection worldwide, affecting at
least 50 million people every year and endemic in more than 100 countries. The dengue …

Dengue fever (DF) and dengue hemorrhagic fever (DHF) are important arthropod-borne
viral diseases. Each year, there are~ 50 million dengue infections and~ 500,000 individuals …

Objective Thrombocytopenia in dengue fever is a common and serious complication.
However, no specific treatment is available for dengue fever induced thrombocytopenia. In …

Dengue infections are a significant cause of morbidity and mortality and lead to adverse
economic effects in many developing tropical countries. In this study, we estimated the …

Background Dengue is an emerging threat to public health. At present, no clear modalities
are available for the prevention and management of thrombocytopenia due to dengue. This …

Thrombocytopenia and platelet dysfunction commonly occur in both dengue and COVID-19
and are related to clinical outcomes. Coagulation and fibrinolytic pathways are activated …

Dengue fever has emerged as a global public health problem in the recent decades. The
clinical spectrum of the disease ranges from dengue fever to dengue hemorrhagic fever and …